We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+10.57%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$1.52B
AUM Growth
+$149M
Cap. Flow
+$21.3M
Cap. Flow %
1.41%
Top 10 Hldgs %
42.95%
Holding
104
New
3
Increased
64
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$12.9M
2
SNOW icon
Snowflake
SNOW
+$10M
3
ADPT icon
Adaptive Biotechnologies
ADPT
+$5.7M
4
OGN icon
Organon & Co
OGN
+$1.9M
5
MSFT icon
Microsoft
MSFT
+$1.41M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$16.1M
2
AYX
Alteryx Inc
AYX
+$6.07M
3
QRVO icon
Qorvo
QRVO
+$3.5M
4
MRK icon
Merck
MRK
+$2.06M
5
GTLS
Chart Industries
GTLS
+$610K

Sector Composition

Rank Sector Weight
1 Technology 30.49%
2 Healthcare 20.63%
3 Consumer Discretionary 12.82%
4 Industrials 11.64%
5 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.99T
$130M 8.55%
478,444
+5,566
+1% +$1.41M
AMZN icon
2
Amazon
AMZN
$2.69T
$86.1M 5.68%
500,760
+6,360
+1% +$1.06M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.3T
$79.4M 5.23%
650,040
+9,460
+1% +$1.1M
NVDA icon
4
NVIDIA
NVDA
$4.92T
$67.1M 4.43%
3,354,800
+18,760
+0.6% +$301K
AME icon
5
Ametek
AME
$53.9B
$60.1M 3.96%
450,013
+3,614
+0.8% +$484K
ADBE icon
6
Adobe
ADBE
$93.3B
$54.3M 3.58%
92,734
+478
+0.5% +$246K
V icon
7
Visa
V
$686B
$51.8M 3.42%
221,508
+1,764
+0.8% +$403K
MRK icon
8
Merck
MRK
$307B
$45M 2.97%
578,210
-27,754
-5% -$2.06M
TECH icon
9
Bio-Techne
TECH
$11.2B
$40.6M 2.68%
360,408
+4,380
+1% +$461K
NXPI icon
10
NXP Semiconductors
NXPI
$67.5B
$37.3M 2.46%
181,175
+86
+0% +$17.2K
IDXX icon
11
Idexx Laboratories
IDXX
$44.5B
$33.4M 2.2%
52,867
+25
+0% +$13.8K
UNP icon
12
Union Pacific
UNP
$176B
$32.3M 2.13%
147,000
– –
HD icon
13
Home Depot
HD
$332B
$32.3M 2.13%
101,140
+1,402
+1% +$446K
PLD icon
14
Prologis
PLD
$138B
$29.9M 1.97%
250,376
+2,021
+0.8% +$236K
TMO icon
15
Thermo Fisher Scientific
TMO
$196B
$29.9M 1.97%
59,320
+675
+1% +$318K
MSCI icon
16
MSCI
MSCI
$45.5B
$29.7M 1.96%
55,749
+21
+0% +$10K
COST icon
17
Costco
COST
$415B
$29.6M 1.95%
74,903
+797
+1% +$301K
ADPT icon
18
Adaptive Biotechnologies
ADPT
$3.5B
$29.3M 1.93%
717,650
+146,708
+26% +$5.7M
EXPE icon
19
Expedia Group
EXPE
$31.8B
$29.2M 1.92%
178,123
+158
+0.1% +$27.1K
GPN icon
20
Global Payments
GPN
$22.5B
$29.1M 1.92%
155,084
+94
+0.1% +$18.9K
NSC icon
21
Norfolk Southern
NSC
$75.2B
$26.5M 1.75%
99,700
+2,111
+2% +$583K
CRM icon
22
Salesforce
CRM
$142B
$26M 1.72%
106,589
+55
+0.1% +$12.7K
TWLO icon
23
Twilio
TWLO
$31.2B
$25.4M 1.68%
64,455
+58
+0.1% +$20.1K
TFX icon
24
Teleflex
TFX
$5.93B
$24.8M 1.64%
61,839
+768
+1% +$315K
AAPL icon
25
Apple
AAPL
$4.8T
$24.3M 1.6%
177,148
+9,695
+6% +$1.26M
1
2 3 4 5

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

Aristotle Atlantic Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Aristotle Atlantic Partners held 104 positions worth $1.52B, up 11% from $1.37B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Aristotle Atlantic Partners's Q2 2021 filing shows 3 new, 64 increased, 4 reduced and 3 closed positions. Its largest new stake was Vertex Pharmaceuticals: 61,548 shares worth $12.4M. The largest sale was Cigna, an estimated $16.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aristotle Atlantic Partners's largest Q2 2021 buy was Vertex Pharmaceuticals: 61,548 shares worth $12.4M.
  • Aristotle Atlantic Partners added most to Adaptive Biotechnologies in Q2 2021, an estimated $5.7M increase.
  • Aristotle Atlantic Partners's biggest Q2 2021 reduction was Cigna, cutting an estimated $16.1M.
  • Aristotle Atlantic Partners fully exited Alteryx Inc in Q2 2021, selling an estimated $6.07M.
  • Aristotle Atlantic Partners's ten largest holdings make up 43% of its $1.52B portfolio in Q2 2021.
  • Aristotle Atlantic Partners opened 3 new positions and closed 3 in Q2 2021.
  • Aristotle Atlantic Partners's portfolio value rose 11% quarter-over-quarter to $1.52B.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2021, filed 16 Aug 2021.